Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Maheux

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Molecular Human Reproduction|March 30, 2001
Interleukin-1 receptor accessory protein is constitutively expressed in human endometrium throughout the menstrual cycleF Bigonnesse, M Marois, R Maheux, et al.
In Vivo (Athens, Greece)|November 1, 1992
Leiomyoma-derived growth factors for smooth muscle cellsM Koutsilieris, D Elmeliani, G Frenette, et al.
Neuropharmacology|April 1, 1986
Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRHL E Tremblay, R Maheux, P J Bédard
Human Reproduction (Oxford, England)|February 28, 2007
Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosisAli Akoum, C Lawson, C Herrmann-Lavoie, et al.
Reproduction (Cambridge, England)|January 25, 2007
Increased expression of interleukin-1 receptor type 1 in active endometriotic lesionsC Lawson, M Al-Akoum, R Maheux, et al.
American Journal of Obstetrics and Gynecology|February 1, 1988
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosisA Lemay, R Maheux, C Huot, et al.
Human Reproduction (Oxford, England)|October 1, 1996
Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroidsA Akoum, A Lemay, I Paradis, et al.
Contraception|March 1, 1997
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
American Journal of Obstetrics and Gynecology|November 16, 1999
Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
Human Reproduction (Oxford, England)|April 1, 1991
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot studyR Maheux, A Lemay, P Blanchet, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Molecular Human Reproduction|March 30, 2001
Interleukin-1 receptor accessory protein is constitutively expressed in human endometrium throughout the menstrual cycleF Bigonnesse, M Marois, R Maheux, et al.
In Vivo (Athens, Greece)|November 1, 1992
Leiomyoma-derived growth factors for smooth muscle cellsM Koutsilieris, D Elmeliani, G Frenette, et al.
Neuropharmacology|April 1, 1986
Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRHL E Tremblay, R Maheux, P J Bédard
Human Reproduction (Oxford, England)|February 28, 2007
Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosisAli Akoum, C Lawson, C Herrmann-Lavoie, et al.
Reproduction (Cambridge, England)|January 25, 2007
Increased expression of interleukin-1 receptor type 1 in active endometriotic lesionsC Lawson, M Al-Akoum, R Maheux, et al.
American Journal of Obstetrics and Gynecology|February 1, 1988
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosisA Lemay, R Maheux, C Huot, et al.
Human Reproduction (Oxford, England)|October 1, 1996
Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroidsA Akoum, A Lemay, I Paradis, et al.
Contraception|March 1, 1997
A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
American Journal of Obstetrics and Gynecology|November 16, 1999
Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG)D F Archer, R Maheux, A DelConte, et al.
Human Reproduction (Oxford, England)|April 1, 1991
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot studyR Maheux, A Lemay, P Blanchet, et al.
Pageof 5